Aehr Test Systems (NASDAQ:AEHR) Issues Q3 2024 Earnings Guidance

Aehr Test Systems (NASDAQ:AEHR) issued an update on its third quarter 2024 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of -0.040–0.030 for the period, compared to the consensus estimate of 0.130. The company issued revenue guidance of $7.6 million-$7.6 million, compared to the consensus revenue estimate of $14.3 million. Aehr Test Systems also updated its FY 2024 guidance to 0.480- EPS.

Aehr Test Systems Price Performance

Shares of AEHR stock opened at $12.46 on Thursday. The business’s fifty day moving average price is $15.92 and its 200 day moving average price is $25.51. The firm has a market capitalization of $359.47 million, a PE ratio of 17.55 and a beta of 2.01. Aehr Test Systems has a 1-year low of $10.53 and a 1-year high of $54.10.

Aehr Test Systems (NASDAQ:AEHR) last announced its quarterly earnings results on Tuesday, January 9th. The semiconductor company reported $0.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. Aehr Test Systems had a net margin of 25.76% and a return on equity of 26.97%. The business had revenue of $21.43 million during the quarter, compared to the consensus estimate of $20.10 million. Equities research analysts expect that Aehr Test Systems will post 0.72 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AEHR. William Blair reiterated a market perform rating on shares of Aehr Test Systems in a research report on Monday. Craig Hallum reiterated a hold rating and issued a $12.00 price objective on shares of Aehr Test Systems in a research report on Tuesday. Finally, StockNews.com raised shares of Aehr Test Systems from a sell rating to a hold rating in a research note on Friday, January 19th.

Insider Buying and Selling

In other news, CEO Gayn Erickson sold 4,871 shares of the business’s stock in a transaction that occurred on Thursday, January 18th. The shares were sold at an average price of $17.39, for a total value of $84,706.69. Following the completion of the transaction, the chief executive officer now owns 427,935 shares of the company’s stock, valued at $7,441,789.65. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Gayn Erickson sold 4,871 shares of the firm’s stock in a transaction on Thursday, January 18th. The stock was sold at an average price of $17.39, for a total transaction of $84,706.69. Following the sale, the chief executive officer now owns 427,935 shares in the company, valued at $7,441,789.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Avijit K. Ray-Chaudhuri bought 3,000 shares of Aehr Test Systems stock in a transaction that occurred on Friday, January 12th. The shares were acquired at an average price of $17.87 per share, for a total transaction of $53,610.00. Following the completion of the transaction, the vice president now directly owns 9,719 shares of the company’s stock, valued at approximately $173,678.53. The disclosure for this purchase can be found here. In the last quarter, insiders sold 8,738 shares of company stock worth $151,723. 6.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Aehr Test Systems

A number of institutional investors have recently bought and sold shares of AEHR. Lazard Asset Management LLC purchased a new stake in Aehr Test Systems during the fourth quarter valued at about $34,000. Deutsche Bank AG purchased a new position in shares of Aehr Test Systems in the 1st quarter worth about $40,000. PNC Financial Services Group Inc. lifted its stake in shares of Aehr Test Systems by 93.0% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,158 shares of the semiconductor company’s stock valued at $48,000 after purchasing an additional 558 shares in the last quarter. Citigroup Inc. grew its holdings in shares of Aehr Test Systems by 463.8% during the 4th quarter. Citigroup Inc. now owns 2,458 shares of the semiconductor company’s stock worth $49,000 after purchasing an additional 2,022 shares during the period. Finally, JPMorgan Chase & Co. increased its position in Aehr Test Systems by 1,027.1% during the 1st quarter. JPMorgan Chase & Co. now owns 1,578 shares of the semiconductor company’s stock worth $49,000 after purchasing an additional 1,438 shares in the last quarter. 69.69% of the stock is currently owned by hedge funds and other institutional investors.

About Aehr Test Systems

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.